Long Ideas - Amarin Corp. (NASDAQ:AMRN) got a bump in the pre-market Tuesday after announcing that two more patents have been added to Vascepa’s Intellectual Property, protecting the … Continue Reading
Read nowQuick Picks - The competition among obesity-drug makers continues to heat up Monday following an announcement from Orexigen Therapeutics (NASDAQ:OREX) that the company may be able to expedite the approval … Continue Reading
Read nowLong Ideas - DARA BioSciences (NASDAQ:DARA) released some much-needed positive news Monday morning, reporting the domestic launch of Soltamox, the first oral, liquid formulation of the breast-cancer drug … Continue Reading
Read nowMost Popular - PropThink published its latest report on Keryx Biopharmaceuticals last week, and on Monday we followed up with some technical discussion. We also included QCOR in … Continue Reading
Read nowShort Ideas - Puma Biotechnology (NYSE:PBYI) uplisted to the New York Stock Exchange from the OTC Bulletin Board on Friday, generating significant trading interest in the stock and a 40% … Continue Reading
Read nowLong Ideas - Novo Nordisk (NYSE:NVO) already set a new 52-week high this week of $167.74, and shares are poised to again break that high Friday. A European … Continue Reading
Read nowMost Popular - Geron Corp (NASDAQ:GERN) may have finally found a buyer for its suspended stem cell program. The company has been searching since November of 2011 when … Continue Reading
Read now